Clinical trial
Monocenter, Double Blinded, Prospective, Randomized Placebo Controlled Study Investigating Prevention of Major Adverse Cardiac Events (MACEs) Within 6 Months by Systemic Treatment With Everolimus After Coronary Intervention With Bare Metal Stents in Patients With Significant Coronary Artery Disease
NCT00426049 is registered in ClinicalTrials.gov with German Heart Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Monocenter, Double Blinded, Prospective, Randomized Placebo Controlled Study Investigating Prevention of Major Adverse Cardiac Events (MACEs) Within 6 Months by Systemic Treatment With Everolimus After Coronary Intervention With Bare Metal Stents in Patients With Significant Coronary Artery Disease
- Lead sponsor
- German Heart Institute
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- October 31, 2006
- Completion date
- Not reported
- Enrollment
- 484
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.